Donepezil, galantamine, and rivastigmine are acetylcholinesterase inhibitors that have been approved by both the Food and Drug Administration and the European Medicines Agency for the treatment of AD [194,195]. The gene discussed is ACHE; the disease is Alzheimer disease.